Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
Sijin Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie He(First Affiliated Hospital of Jinan University), Zhenlin Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Yibo Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yannan Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Wang(Qingdao University), Guochao Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Xue(Chinese Academy of Medical Sciences & Peking Union Medical College), Juhong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Kailun Fei(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 25
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Cancer registration in China and its role in cancer prevention and control
|The Lancet Oncology|2020|501
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415